drug

Antiaging Treatments that are Closest to FDA Approval

Posted in Medicine on 17th Jan, 2020
by Alex Muller

There are a few dozen antiaging rejuvenation treatments that are progressing through pre-clinical and clinical trials. Lifespan.io is tracking the antiaging rejuvenation treatments on a rejuvenation roadmap. Two treatments are in phase 3 clinical trial.

New oral migraine prevention drug approved by FDA

Posted in Medicine on 24th Dec, 2019
by Alex Muller

Continuing the wave of cutting-edge new migraine drugs reaching the American market, the U.S. Food and Drug Administration (FDA) has now approved the first oral calcitonin gene-related peptide (CGRP) antagonist for acute migraine treatment.

Drug targeting common cancer cause enters phase 2 clinical trials

Posted in Medicine on 24th Dec, 2019
by Alex Muller

Known as AMG 510, the drug targets a gene mutation that’s one of the most common causes of cancer.

Microdosing LSD for Alzheimer’s proves safe in early human trial

Posted in Medicine on 20th Dec, 2019
by Alex Muller

New results have been published from one of the first placebo-controlled clinical trials investigating the effects of microdosing LSD. This Phase 1 trial is the first step in testing whether these kinds of psychedelic microdose methods could be useful as a therapeutic approach for treating Alzheimer’s disease

Scientists edit addiction memories with ketamine to treat alcoholism

Posted in Highlights from UCL, Medicine on 27th Nov, 2019
by Alex Muller

An incredible new experimental study from University College London has found a specifically timed infusion of ketamine can effectively rewrite reward memories